IP Library Assignment 042258/0517
Patent Assignment
Reel/Frame 042258/0517

Assignment of Assignor's Interest

Recorded: 2017-05-05 Pages: 6
Assignors
ZHANG, XIAOMING
Executed: 2013-06-21
SCHNIPPER, EDWARD F.
Executed: 2013-06-21
PERLMAN, ANDREW J.
Executed: 2013-06-24
LARRICK, JAMES W.
Executed: 2013-06-21
Assignee
TIGERCAT PHARMA, INC.
400 OYSTER POINT BLVD., SUITE 202, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (6)
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,198,898 →
Application: 14/312,942 →
Publication: US 2015/0057255
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Patent: 9,486,439 →
Application: 14/899,255 →
Publication: US 2016/0143882
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,381,188 →
Application: 14/922,684 →
Publication: US 2016/0038462
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,474,741 →
Application: 15/175,358 →
Publication: US 2016/0279100
Use of Nk-1 Receptor Antagonist Serlopitant in Pruritus
Patent: 9,737,507 →
Application: 15/269,792 →
Publication: US 2017/0065557
Use of Nk-1 Receptor Antagonists in Pruritus
Patent: 9,737,508 →
Application: 15/271,103 →
Publication: US 2017/0065558
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 22, 2014
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 033594/0099 →
Change of Name Jul 6, 2016
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 039197/0765 →
Assignment of Assignor's Interest May 5, 2017
From: ZHANG, XIAOMING; SCHNIPPER, EDWARD F.; PERLMAN, ANDREW J.; LARRICK, JAMES W.
To: TIGERCAT PHARMA, INC.
Reel/Frame 042259/0057 →
Change of Name May 5, 2017
From: TIGERCAT PHARMA, INC.
To: MENLO THERAPEUTICS INC.
Reel/Frame 042418/0481 →
Patent Security Agreement Mar 9, 2020
From: MENLO THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 052130/0980 →
Change of Name Dec 1, 2020
From: MENLO THERAPEUTICS INC.
To: VYNE THERAPEUTICS INC.
Reel/Frame 054558/0437 →
Release of Security Interest Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057531/0986 →